Quote For Dynavax Technologies Corporation DVAX.O
Dynavax Technologies Corporation (DVAX.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector: Healthcare ·
industry: Biotechnology ·
$1.28
27 Nov 2009
-1.54%
$1.30
$1.27
73,096
$1.33
$1.26
$3.35
$0.20
3.05
202,445
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Oronsky, Arnold | Chairman of the Board | -- |
| Dina, Dino | President, Chief Executive Officer, Director | 1,089,305 |
| Janowicz, Zbigniew | Chief Executive Officer, Managing Director of Rhein Biotech GmbH (Dynavax Europe) | 687,528 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $52.84 |
| Shares Outstanding (Mil.) | 41.28 |
| Float (Mil.) | 40.20 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 1.87 |
| Current Ratio | 4.28 |
| LT Debt/Equity | 0.00 |
| Total Debt/Equity | 0.00 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 17.90 |
| Price/Sales(TTM) | 1.06 |
| Price/Book(TTM) | 2.92 |
| Price/Cash Flow(TTM) | 33.63 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $0.07 |
| Sales(TTM) | $1.25 |
| Book Value(MRQ) | $0.44 |
| Cash Flow(TTM) | $0.04 |
| Cash(MRQ) | $0.60 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 20.11 |
| Return on Assets(TTM) | -1.78 |
| Return on Investment(TTM) | -2.31 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 29.20 |
| Operating Margin(TTM) % | -3.21 |
| Profit Margin(TTM) % | -2.65 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
